PRPH
ProPhase Labs, Inc. Common Stock (DE)
PHARMACEUTICAL PREPARATIONS
Best Pharmaceutical Stocks 2026 →
PRPH Stock Analysis: Buy, Sell, or Hold?
$0.36
-0.08 (-18.97%)
▼
5d:
-39.58%
30d:
+157.16%
90d:
-33.69%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (76%)
Quality Score
40/100
Position
FAIR
Forward P/E & Valuation
10.1x
Next 12M consensus est.
Wall Street Target
$13.80
+3705.8% upside
Options IV & Volume
UNKNOWN Vol
UNKNOWN volume confirmation
Support / Resistance
$0.08 / $1.15
Trend: Sideways
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
⏸️ WAIT FOR STABILIZATION: PRPH is down 39.6% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
Get Alerted When PRPH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: PRPH is currently trading at $0.36, which is considered fair based on recent price action.
Technical Outlook: Technically, PRPH is showing sideways momentum. Immediate support is located at $0.08, while resistance sits at $1.15. Short-term momentum is weak, with the stock down 19.0% recently.
Market Sentiment: PRPH scores 75/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $13.80 (+3705.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, PRPH is showing sideways momentum. Immediate support is located at $0.08, while resistance sits at $1.15. Short-term momentum is weak, with the stock down 19.0% recently.
Market Sentiment: PRPH scores 75/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $13.80 (+3705.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Company Quality Score
40/100
(HOLD)
Volume Confirmation
UNKNOWN
Confidence Score
76.3%
Trading Range & Key Levels
Support Level
$0.08
Resistance Level
$1.15
Current Trend
Sideways
Technical data as of
Jan 2, 2026
Quantitative Signal Breakdown
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (75/100)
- BEARISH: Downward momentum (-19.0%)
- BULLISH: Trading 3705.8% below Wall St target ($13.80)
- WARNING: Composite score 40/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
10.09
Wall Street Target
$13.80
(+3705.8%)
Revenue Growth (YoY)
-37.6%
Earnings Growth (YoY)
-95.2%
Share PRPH Analysis
Share this live PRPH analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (PRPH)
Neutral
2 Retail Mentions
StockTwits Volume
2 msgs
24h retail stream
Last Tracked
Jan 5, 2026
Daily AI digest
AI Retail Discussion Summary:
ProPhase Labs (PRPH) experienced significant share price volatility due to the conversion of convertible debt and a reverse stock split. The latest news update explains that over $3.3 million of convertible debt has been converted, reducing debt and increasing equity. The remaining unconverted balance is less than $500,000, and recent conversions occurred at a floor price of $0.76 per share.
Key Retail Themes:
capital structure changes
convertible debt conversion
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 9:46 PM ET
Data refreshes hourly during market hours. Next update: 10:46 PM
Data refreshes hourly during market hours. Next update: 10:46 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PRPH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
GH
Guardant Health Inc |
STRONG BUY
26 analysts |
$201 | 51 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
23 analysts |
$416 | 65 BUY |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 52 HOLD |
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
27 analysts |
$752 | 47 HOLD |
|
DHR
Danaher Corporation |
STRONG BUY
24 analysts |
$260 | 51 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive PRPH Research Pages
